Myelodysplastic/myeloproliferative diseases Trials in Cleveland, United States
Conditions / Myelodysplastic/myeloproliferative diseases / Cleveland, United States
Myelodysplastic/myeloproliferative diseases is a medical condition with active clinical research programs worldwide.
14 total trials for this combination
Showing top 10 of 14 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00054236 | Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia | COMPLETED | PHASE1 |
| NCT00003335 | Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer | COMPLETED | PHASE2 |
| NCT00006379 | Non-Ablative Allo HSCT For Hematologic Malignancies or SAA | COMPLETED | PHASE2 |
| NCT00109993 | Campath-1H + FK506 and Methylprednisolone for GVHD | COMPLETED | PHASE2 |
| NCT00281814 | Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant | COMPLETED | — |
| NCT00003913 | Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease | COMPLETED | PHASE2 |
| NCT00068523 | Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies | COMPLETED | NA |
| NCT00055653 | Donor Umbilical Cord Blood Transplantation in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders | COMPLETED | PHASE2 |
| NCT00281801 | Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation | COMPLETED | — |
| NCT00003116 | High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer | COMPLETED | PHASE2 |